載入...
Robust CD8(+) T-cell proliferation and diversification after mogamulizumab in patients with adult T-cell leukemia-lymphoma
Skin-related adverse events (AEs) occur frequently in adult T-cell leukemia-lymphoma (ATL) patients treated with mogamulizumab, a humanized anti-CCR4 monoclonal antibody. This study was undertaken to elucidate the mechanisms of mogamulizumab-induced skin-related AEs. We analyzed the T-cell receptor...
Na minha lista:
| 發表在: | Blood Adv |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Hematology
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7252545/ https://ncbi.nlm.nih.gov/pubmed/32433748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001641 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|